Postconcussion syndrome: a review of pathophysiology and potential nonpharmacological approaches to treatment (Q38073087)

28 August 2017

1 reference

title

Postconcussion syndrome: a review of pathophysiology and potential nonpharmacological approaches to treatment (English)

1 reference

28 August 2017

Joseph C Maroon

1

1 reference

28 August 2017

Darren B Lepere

series ordinal

2

1 reference

28 August 2017

Russell L Blaylock

series ordinal

3

1 reference

28 August 2017

Jeffrey W Bost

series ordinal

4

1 reference

28 August 2017

language of work or name

English

0 references

publication date

1 November 2012

1 reference

The Physician and Sportsmedicine

28 August 2017

1 reference

28 August 2017

40

1 reference

28 August 2017

4

1 reference

28 August 2017

73-87

1 reference

Care of war veterans with mild traumatic brain injury--flawed perspectives

28 August 2017

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Mild traumatic brain injury: pathophysiology, natural history, and clinical management

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Outcome after mild traumatic brain injury: an examination of recruitment bias

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Persistent Post-Concussive Syndrome: A proposed methodology and literature review to determine the effects, if any, of mild head and other bodily injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Evaluating the utility of ICD-10 diagnostic criteria for postconcussion syndrome following mild traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Should we treat concussion pharmacologically? The need for evidence based pharmacological treatment for the concussed athlete

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Mild traumatic brain injury: toward understanding manifestations and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

21 January 2018

Post concussion syndrome

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Cognition in the days following concussion: comparison of symptomatic versus asymptomatic athletes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

MR imaging in the detection of diffuse axonal injury with mild traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Computed tomography and magnetic resonance imaging in mild to moderate head injury: early and late imaging related to outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Neuropsychological, MRI and EEG findings after very mild traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Immunoexcitotoxicity as a central mechanism in chronic traumatic encephalopathy-A unifying hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Microglia in the aging brain: relevance to neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Non-steroidal anti-inflammatory drugs (NSAIDs) and other anti-inflammatory agents in the treatment of neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Imaging of microglia in patients with neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Cytokines and cognition--the case for a head-to-toe inflammatory paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

From the field of play to the field of combat: a review of the pharmacological management of concussion

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Natural plant products and extracts that reduce immunoexcitotoxicity-associated neurodegeneration and promote repair within the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Natural anti-inflammatory agents for pain relief

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

n-3 fatty acids specifically modulate catabolic factors involved in articular cartilage degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Pathologic indicators of degradation and inflammation in human osteoarthritic cartilage are abrogated by exposure to n-3 fatty acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Biological basis for the benefit of nutraceutical supplementation in arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Pycnogenol inhibits tumor necrosis factor-alpha-induced nuclear factor kappa B activation and adhesion molecule expression in human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Treatment of chronic postherpetic neuralgia with topical capsaicin. A preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Omega-3 fatty acids (fish oil) as an anti-inflammatory: an alternative to nonsteroidal anti-inflammatory drugs for discogenic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

The Omega-3 Index: a new risk factor for death from coronary heart disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Short-time infusion of fish oil-based lipid emulsions, approved for parenteral nutrition, reduces monocyte proinflammatory cytokine generation and adhesive interaction with endothelium in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Neuroprotective actions of eicosapentaenoic acid on lipopolysaccharide-induced dysfunction in rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Body mass and encephalization in Pleistocene Homo

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Evolutionary perspectives on human nutrition: The influence of brain and body size on diet and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

The Expensive-Tissue Hypothesis: The Brain and the Digestive System in Human and Primate Evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Fatty acid composition and energy density of foods available to African hominids. Evolutionary implications for human brain development

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Docosahexaenoic acid reduces traumatic axonal injury in a rodent head injury model

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Stuck at the bench: Potential natural neuroprotective compounds for concussion

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Neuroprotective effect of docosahexaenoic acid on glutamate-induced cytotoxicity in rat hippocampal cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Brain response to injury and neurodegeneration: endogenous neuroprotective signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Docosahexaenoic acid suppresses neuroinflammatory responses and induces heme oxygenase-1 expression in BV-2 microglia: implications of antidepressant effects for ω-3 fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Neuroprotective effect of developmental docosahexaenoic acid supplement against excitotoxic brain damage in infant rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Neuroprotection of rat hippocampal slices exposed to oxygen-glucose deprivation by enrichment with docosahexaenoic acid and by inhibition of hydrolysis of docosahexaenoic acid-containing phospholipids by calcium independent phospholipase A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

AMPA receptor-mediated cell death is reduced by docosahexaenoic acid but not by eicosapentaenoic acid in area CA1 of hippocampal slice cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Docosahexaenoic acid promotes neurite growth in hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Effects of docosahexaenoic acid on the survival and neurite outgrowth of rat cortical neurons in primary cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Omega-3 polyunsaturated fatty acids increase the neurite outgrowth of rat sensory neurones throughout development and in aged animals.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Vitamin D revisited: a cornerstone of health?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

The role of 25-hydroxyvitamin D deficiency in promoting insulin resistance and inflammation in patients with chronic kidney disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Vitamin D and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

1alpha,25-dihydroxy-vitamin D3 in combination with 17beta-estradiol lowers the cortical expression of heat shock protein-27 following experimentally induced focal cortical ischemia in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

A combined treatment with 1alpha,25-dihydroxy-vitamin D3 and 17beta-estradiol reduces the expression of heat shock protein-32 (HSP-32) following cerebral cortical ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Membrane receptors for steroid hormones: a case for specific cell surface binding sites for vitamin D metabolites and estrogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Progesterone exerts neuroprotective effects after brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Vitamin D deficiency reduces the benefits of progesterone treatment after brain injury in aged rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Traumatic brain injury and aging: is a combination of progesterone and vitamin D hormone a simple solution to a complex problem?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Interleukin-10 promoter polymorphism in sporadic Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

1,25-dihydroxyvitamin D3 modulates cytokine production induced by Candida albicans: impact of seasonal variation of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

1,25-Dihydroxyvitamin D₃ suppresses inflammation-induced expression of plasminogen activator inhibitor-1 by blocking nuclear factor-κB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Vitamin D intake needed to maintain target serum 25-hydroxyvitamin D concentrations in participants with low sun exposure and dark skin pigmentation is substantially higher than current recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Vitamin D insufficiency among free-living healthy young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

The importance of using scientific principles in the development of medicinal agents from plants

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Lipopolysaccharide-mediated reactive oxygen species and signal transduction in the regulation of interleukin-1 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Curcumin prevents alcohol-induced liver disease in rats by inhibiting the expression of NF-kappa B-dependent genes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Cyclooxygenase inhibitory natural products: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Curcumin, an atoxic antioxidant and natural NFkappaB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Curcumin attenuates cerebral edema following traumatic brain injury in mice: a possible role for aquaporin-4?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Dose dependence and therapeutic window for the neuroprotective effects of curcumin in thromboembolic model of rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Curcumin improves outcomes and attenuates focal cerebral ischemic injury via antiapoptotic mechanisms in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Neuroprotective effect of curcumin on focal cerebral ischemic rats by preventing blood-brain barrier damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Therapeutic potential of resveratrol: the in vivo evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Resveratrol improves health and survival of mice on a high-calorie diet

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Cardiovascular protective effects of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Neuroprotective properties of resveratrol and derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Resveratrol reduces the elevated level of MMP-9 induced by cerebral ischemia-reperfusion in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Resveratrol and health--a comprehensive review of human clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Effects of resveratrol in inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Resveratrol, a natural red wine polyphenol, reduces ischemia-reperfusion-induced spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Neuroprotective effects of resveratrol against traumatic brain injury in immature rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Resveratrol attenuates behavioral impairments and reduces cortical and hippocampal loss in a rat controlled cortical impact model of traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Neuroprotective effects of resveratrol on ischemic injury mediated by modulating the release of neurotransmitter and neuromodulator in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Bilberry juice modulates plasma concentration of NF-kappaB related inflammatory markers in subjects at increased risk of CVD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Neuroprotection by resveratrol against traumatic brain injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Voltage-dependent block by intracellular Mg2+ of N-methyl-D-aspartate-activated channels

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Effects of magnesium sulfate on energy metabolites and glutamate in the cortex during focal cerebral ischemia and reperfusion in the gerbil monitored by a dual-probe microdialysis technique

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Role of excitatory amino acid-mediated ionic fluxes in traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Traumatic brain axonal injury produces sustained decline in intracellular free magnesium concentration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Severe hypomagnesaemia in long-term users of proton-pump inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Magnesium deficiency exacerbates and pretreatment improves outcome following traumatic brain injury in rats: 31P magnetic resonance spectroscopy and behavioral studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Magnesium for fetal neuroprotection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Use of magnesium in traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

A green tea-derived polyphenol, epigallocatechin-3-gallate, inhibits IkappaB kinase activation and IL-8 gene expression in respiratory epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Interleukin (IL)-1 receptor-associated kinase (IRAK) requirement for optimal induction of multiple IL-1 signaling pathways and IL-6 production

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

IL-1 receptor-associated kinase modulates host responsiveness to endotoxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Green tea increases anti-inflammatory tristetraprolin and decreases pro-inflammatory tumor necrosis factor mRNA levels in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Catechin and caffeine content of green tea dietary supplements and correlation with antioxidant capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Hypovitaminosis D in Medical Inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2012.11.1990

Biological activities of Curcuma longa L.

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1590/S0074-02762001000500026

Identifiers

DOI

10.3810/PSM.2012.11.1990

1 reference

28 August 2017

1 reference